Lv1
30 积分 2025-09-24 加入
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): a multicenter randomized controlled trial
5个月前
已完结
Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for Pancreatic Ductal Adenocarcinoma
7个月前
已完结
Optimizing the outcomes of pancreatic cancer surgery
7个月前
已完结
Neoadjuvant therapy for pancreatic cancer
7个月前
已完结
Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review
8个月前
已完结
Primary Treatment Modification and Treatment Tolerability Among Older Chemotherapy Recipients With Advanced Cancer
8个月前
已完结
Treatment landscape of metastatic pancreatic cancer
8个月前
已完结
Safety and Efficacy of Conversion Therapy After Systemic Chemotherapy in Advanced Esophageal Cancer with Distant Metastases: A Multicenter Retrospective Observational Study
9个月前
已完结
Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial
9个月前
已完结
HIF-2 in Cancer-Associated Fibroblasts Polarizes Macrophages and Creates an Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
9个月前
已完结
皖公网安备34019202002308
